2007
DOI: 10.1016/s0145-2126(07)70370-3
|View full text |Cite
|
Sign up to set email alerts
|

P022 Evaluation of some hemostatic parameters in patients with end-stage renal disease: relation to dyslipidemia and hemodialysis therapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

1
0
0

Year Published

2020
2020
2020
2020

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
1
0
0
Order By: Relevance
“…The present study documented that mean plasma fibrinogen of ESRD patients was significantly higher than that of controls, (P<0.001), in line with the findings of a recent Egyptian study in 2013 which found a significant increase in plasma fibrinogen which might contribute to the hypercoagulability in ESRD patients. (21) The present study found that AT activity was significantly lower in ESRD patients than controls, (P<0.001). This finding agreed the findings of previous studies, Vaziri and his colleagues (23) which found that AT activity and concentration were significantly reduced in ESRD patients.…”
Section: Discussionsupporting
confidence: 47%
“…The present study documented that mean plasma fibrinogen of ESRD patients was significantly higher than that of controls, (P<0.001), in line with the findings of a recent Egyptian study in 2013 which found a significant increase in plasma fibrinogen which might contribute to the hypercoagulability in ESRD patients. (21) The present study found that AT activity was significantly lower in ESRD patients than controls, (P<0.001). This finding agreed the findings of previous studies, Vaziri and his colleagues (23) which found that AT activity and concentration were significantly reduced in ESRD patients.…”
Section: Discussionsupporting
confidence: 47%